Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000729734 | SCV000857421 | uncertain significance | not provided | 2017-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001485702 | SCV001690148 | likely benign | Wolman disease | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Elsea Laboratory, |
RCV001250116 | SCV001424299 | likely benign | Lysosomal acid lipase deficiency | 2020-04-01 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001250116 | SCV001464773 | uncertain significance | Lysosomal acid lipase deficiency | 2020-07-28 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004735775 | SCV005348947 | likely benign | LIPA-related disorder | 2024-08-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |